Abstract: Highly enantioselective Pd(II)-catalyzed Michael addition, Mannich-type reaction, aldol reaction, fluorination, conjugate addition of amine, and conjugate reduction have been developed. Asymmetric synthesis of biologically interesting heterocyclic compounds, calycotomine, BMS-204352, torcetrapib, and warfarin, was achieved by using these Pd-catalyzed asymmetric reactions as a key step.
INTRODUCTION
In 1995, we reported the first example of Pd-catalyzed asymmetric aldol reaction of a silyl enol ether via a chiral Pd enolate. Subsequently, two series of stable crystalline Pd complexes having a chiral bidentate phosphine ligand, Pd aqua complexes 1 and µ-hydroxo complexes 2 (Scheme 1), were found to be excellent catalysts for enantioselective aldol [1] and Mannich-type reactions [2] using silyl enol ethers. In these reactions, the chiral Pd enolate was efficiently generated by transmetallation from the silyl enol ether and reacted with aldehydes or imines to afford highly optically active products. Next, the chiral Pd enolates of 1,3-dicarbonyl compounds were found to be generated readily by proton abstraction using these complexes. The monomeric Pd hydroxo complex 3, which can be generated either by deprotonation of the aqua complex 1 or by simple dissociation of the binuclear complex 2, would act as a mild Brønsted base catalyst. The chiral Pd enolates reacted with various electrophiles under acidic conditions. Highly enantioselective Michael addition [3] , Mannich-type reaction [4] , aldol reaction [5] , and fluorination [6] have been achieved (Scheme 1) [7] . These Pd complexes were also found to be effective for enantioselective conjugate addition. The advantages of these catalytic systems include compatibility with various functional groups, and tolerance of air and moisture, and they are useful for the enantioselective synthesis of highly functionalized compounds including nitrogen-containing compounds. In this paper, we focus on the enantioselective syntheses of heterocyclic compounds using these reactions as key steps. imines 4g and 4h were smoothly converted to 8g and 8h in excellent yield with 96 and 90 % ee, respectively. The reaction product 8d was converted to (R)-calycotomine (9) (Scheme 4). 
Reaction mechanism
On the basis of mechanistic studies, we proposed the catalytic cycle outlined in Scheme 5. First, the cyclic imine 4 reacts with (Boc) 2 O to give the N,O-acetal 11 through the carbonate 10. We speculated that a strong protic acid, generated during the formation of the Pd enolate 12, would facilitate formation of the acyl iminium intermediate 13, which would react with 12 to complete the catalytic cycle. In spite of the formation of the highly reactive species, high asymmetric induction was observed under mild conditions, presumably due to cooperative action of the chiral Pd enolate and the proton.
Dehydrogenative Mannich-type reaction of THIQ with malonates
The mechanistic studies led us to envisage that it would be useful if the reactive iminium intermediate could be formed in situ from THIQs. Inspired by the work of Li et al.
[9f], we examined the dehydrogenative Mannich-type reaction with malonate (Scheme 6). Slow addition of DDQ allowed in situ generation of the reactive intermediate, such as 13, from the N-Boc-protected THIQ 14. As we expected, the coupling product 8d was obtained at a synthetically useful level (82 and 86 % ee) [11] . Since preparation of the starting THIQ 14 is easier, this one-pot procedure represents a convenient variation of the reaction with DHIQs.
ENANTIOSELECTIVE FLUORINATION OF HETEROCYCLIC COMPOUNDS
Introduction of fluorine atoms into bioactive compounds is a common approach to improve the biological activity profile [12] . Therefore, catalytic enantioselective fluorination has attracted growing interest [13, 14] . We recently reported Pd-catalyzed fluorination reactions of β-ketoesters and β-ketophosphonates [6a-d]. To examine the scope and limitations of this reaction, we also examined fluorination reactions of less acidic substrates. Here, fluorination of two types of heterocyclic compounds, lactam [15] , and oxindole derivatives [16] are described.
Enantioselective fluorination of lactam substrates
Fluorination of the lactam substrate 15a with N-fluorobenzenesulfonimide (NFSI) was examined, and the ee of the product 16a was determined after conversion to the N-benzylated product 16b. With the Pd aqua complex 1b, which was the best for β-ketoesters, high enantioselectivity (~90 % ee) was generally observed. But the reaction was slow and the chemical yield did not exceed 50 % after even 48 h ( Table 2 , entry 1). Notably, the bulky complex 1d was completely inactive for this less acidic lactam substrate (entry 2). To promote the reaction, we next examined the effect of adding organic bases. When triethylamine (0.5 equiv) was added, the chemical yield was slightly improved (entry 3). Bases that can
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Scheme 5 Proposed reaction mechanism.
Scheme 6 Dehydrogenative Mannich-type reaction.
coordinate to the catalyst inhibited the reaction (entries 5-8), but 2,6-lutidine significantly improved the chemical yield without any loss of enantioselectivity (80 % yield, 91 % ee, entry 9). However, the much bulkier 2,6-(t-Bu) 2 -pyridine was found less effective (entry 10). It should be noted that even 1d and 2d promoted the reactions with the aid of 2,6-lutidine, and the desired product 16a was obtained in modest yield (58 %) with almost complete enantioselectivity (99 % ee, entries 11 and 12). The high selectivity observed in this reaction strongly indicates that additional base alone is insufficient for the activation of the substrate, and the combined use of the Pd complex with 2,6-lutidine is essential for efficient generation of the Pd enolate. The absolute stereochemistry was determined to be R by X-ray analysis, [17] which is in accordance with our previous results (Fig. 1) . Reactions of N-benzylated and N-methylated lactam substrates 15b and 15c proceeded smoothly, and the desired products 16b and 16c were obtained in good yield (89 and 77 %, respectively) with excellent enantioselectivity (98 and 99 % ee, respectively) (Table 3) [15] . Protection of the amide group might suppress the competitive abstraction of the amide proton, favoring the generation of the desired Pd enolate. The N-acylated substrate 15d was also fluorinated in a highly enantioselective manner (99 % ee). In the case of the six-membered substrate 15e, no protection of the amide was necessary, and 16e was obtained in 74 % yield with 94 % ee. Further, this fluorination reaction is potentially useful for the preparation of optically active fluorinated cyclic amines. For example, reduction of 16b by BH 3 in tetrahydrofuran (THF) afforded the corresponding fluoroamine 17 in 60 % yield (Scheme 7). 
Enantioselective fluorination of oxindoles and synthesis of MaxiPost TM
BMS 204352 (MaxiPost TM ) 18, developed by Bristol-Myers Squibb, is a promising agent for the treatment of stroke, and is undergoing phase III clinical trial [18] . Because the oxindole ring is found widely in nature, we thought that asymmetric fluorination of oxindoles would be useful in medicinal chemistry. Initial studies revealed that the reaction of nitrogen-free 3-phenyloxindole was sluggish under the reaction conditions established for β-keto esters, so we next examined the reaction of N-protected oxindoles. To achieve an asymmetric synthesis of the target compound, we selected ortho-MeOphenyl-substituted oxindole as a model substrate. As shown in Scheme 8, various electron-withdrawing groups were tested as a protecting group of the nitrogen atom. Among them, the reaction of N-Boc-protected 19a proceeded smoothly to give 20a in 89 % yield with 76 % ee. To improve the enantioselectivity, several bulkier protecting groups were tested, and a slightly better ee (81 % ee) was observed for the N-fluorenyloxycarbonyl-protected derivative 19i. It is noteworthy that the N-acyl derivatives 19b and 19d gave much lower chemical and optical yields than the corresponding N-alkoxycarbonyl derivatives.
With these results in hand, we applied our reaction to the catalytic asymmetric synthesis of 18 (Scheme 9). Compounds 21 were subjected to the fluorination reaction, and the desired products 22 were obtained in good chemical yield. The reaction of the N-Boc-protected derivative 21a was found to be the most enantioselective, and 22a was isolated in 90 % yield with 71 % ee. After deprotection of 22a with trifluoroacetic acid (TFA), recrystallization furnished optically pure (S)-18 (>99 % ee) [16] .
Importantly, this reaction displayed broad generality as regards substituents at the 3-position. Various other 3-alkyl-or aryl-substituted oxindole derivatives were also fluorinated in a highly enantioselective manner (up to 96 % ee) [16] . 
ENANTIOSELECTIVE SYNTHESIS OF TORCETRAPIB BY CONJUGATE ADDITION OF AMINE
With the success in using a bidentate Pd enolate motif in several asymmetric reactions, we speculated that Pd complexes having two vacant coordination sites would act as bidentate chiral Lewis acids. We developed a highly enantioselective conjugate addition of aromatic amines to α,β-unsaturated imidetype compounds [19] , and employed it in an asymmetric synthesis of torcetrapib [20] .
Catalytic enantioselective conjugate addition of amines
Optically active β-amino acid derivatives are a versatile resource for the synthesis of biologically active nitrogen-containing compounds [21] . It is known that the catalytic enantioselective conjugate addition of highly nucleophilic amine is extremely difficult, because the noncatalyzed process competes with the desired catalyzed process. We found that the catalytic enantioselective conjugate addition of amines to 3-[(E)-2-alkenoyl]oxazolidin-2-one proceeded well with the combined use of the µ-hydroxo complex 2a having a Brønsted base character and amine salts, affording highly optically active products (up to 98 % ee) [19] .
Catalytic enantioselective synthesis of torcetrapib
Torcetrapib (23) is a potent cholesteryl ester transfer protein (CETP) inhibitor [22] , and the compound 24 was reported to be a key synthetic intermediate. We applied our enantioselective conjugate addition reaction to the synthesis of 23. Under the established conditions, however, the reaction of methyl pentenoylcarbamate 25 with the salt of 4-trifluoromethylaniline 26 was slow. This might be attributed to low nucleophilicity of 26 and unfavorable steric interaction with the β-substituent of 25. After examining various reaction conditions, we found that toluene was a better solvent, and slow addition of 26 (0.5 equiv over 12 h) was effective to achieve high chemical yield (Scheme 10). Thus, the Michael adduct 24 was produced in 98 % yield with 89 % ee [20] . This compound was converted to the tetrahydroquinoline derivative 27 by reductive cyclization. Hii et al. also recently reported similar results [23] .
ENANTIOSELECTIVE SYNTHESIS OF WARFARIN BY CONJUGATE REDUCTION
During the course of our examination of enantioselective conjugate addition of indole to 28, we encountered very interesting results. When ethanol was used as the solvent, no conjugate addition occurred. Instead, unexpectedly, the reduced product 29 was formed in quantitative yield (Scheme 11). The structure of the by-product 30 strongly suggested that ethanol acted as an efficient hydride source. Based on this finding, we developed an enantioselective conjugate reduction of α,β-unsaturated ketones, and it was applied to the asymmetric synthesis of warfarin [24] .
Enantioselective conjugate reduction using ethanol as a hydride source
We investigated catalytic enantioselective conjugate reduction of α,β-unsaturated ketones in ethanol [24] . As summarized in Table 4 , various enones 31 were smoothly reduced to give 32 in a highly enantioselective manner using 2.5 mol % of the catalyst 2a. In this reaction, ethanol acts as both a reducing agent and a solvent, and it is environmentally and economically advantageous compared with other conjugate reductions using metal hydride or dihydropyridines as a reducing agent [25] . We proposed the reaction mechanism shown in Scheme 12, based on the results of experiments using deuterium-labeled ethanol. The chiral Pd-hydride complex 34 generated by β-hydride elimination of the Pd ethoxide complex 33 is considered to be a key intermediate [26] .
Catalytic enantioselective synthesis of (S)-warfarin
We applied our novel conjugate reduction to the asymmetric synthesis of warfarin 35, a well-known anti-coagulant (Scheme 13). Although the biological activity of the S enantiomer is about 5-8 times higher than that of the R enantiomer, warfarin has been clinically used as a racemate for a long time [27] . Reaction of dehydrowarfarin was unsuccessful because of facile intramolecular cyclization to give the corresponding mixed ketal. Therefore, we examined the conjugate reduction of 4-Me-dehydrowarfarin 36 (Scheme 13). Gratifyingly, the reaction proceeded smoothly in the presence of the (S)-Pd complex 2a (2.5 mol %) to afford the reduced product 37 quantitatively. The ee of 37 was as high as 96 %. Furthermore, the amount of catalyst could be reduced to as little as 0.25 mol % without any loss of enantioselectivity. Demethylation with BBr 3 , followed by a single recrystallization, gave optically pure (S)-warfarin 35 [24] .
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Scheme 12 Proposed catalytic cycle.
CONCLUSION
We have described highly efficient enantioselective syntheses of heterocyclic compounds using chiral Pd complexes. C1-Substituted THIQs were synthesized by catalytic enantioselective Mannich-type reaction. Fluorine-containing heterocycles such as the drug candidate MaxiPost were synthesized by asymmetric fluorination. A key intermediate for the synthesis of the biologically interesting CEPT inhibitor torcetrapib was obtained by the catalytic asymmetric conjugate addition reaction of amine. The active (S)-form of the clinically important anti-coagulant warfarin was successfully synthesized by using the Pd-catalyzed conjugate reduction with ethanol as a hydride source.
